Healthlead

HL

THA598010009

Drug Retailers

End-of-day quote Thailand S.E. Other stock markets 18:00:00 2024-05-20 EDT			5-day change	1st Jan Change
11.2 ^THB	-0.88%		-5.88%	+7.69%

04-17	Healthlead Public Company Limited Approves Dividend for the Year Ended December 31, 2023, Payable on 10 May 2024	CI
02-29	Healthlead Public Company Limited Announces Management Changes	CI

Healthlead Public Company Limited Proposes Cash Dividend for the Period from January 1, 2022 to December 31, 2022, Payable on May 11, 2023

February 26, 2023 at 07:24 pm

Healthlead Public Company Limited at its AGM to be held on April 12, 2023 proposed cash dividend of THB 0.18 per share for the period from January 1, 2022 to December 31, 2022, payable on May 11, 2023, Record date is March 13, 2023 and Ex-dividend date is March 10, 2023.

Latest news about Healthlead

Healthlead Public Company Limited Approves Dividend for the Year Ended December 31, 2023, Payable on 10 May 2024	04-16	CI
Healthlead Public Company Limited Announces Management Changes	02-29	CI
Healthlead Public Company Limited Proposes Dividend for the Year 2024, Payable Within 10 May 2024	02-28	CI
Healthlead Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023	02-28	CI
Healthlead Public Company Limited Announces Resignation of Ampaivan Limprapassorn, an Independent Director and Chairman of the Audit Committee, Effective from 29Th February 2024	02-20	CI
Healthlead Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-12	CI
Healthlead Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-11	CI
Healthlead Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-14	CI
Healthlead Public Company Limited Approves Dividend for the Year 2022, Payable on May 11, 2023	23-04-12	CI
Healthlead Public Company Limited Announces Accounting Director Changes	23-04-12	CI
Healthlead Public Company Limited Proposes Cash Dividend for the Period from January 1, 2022 to December 31, 2022, Payable on May 11, 2023	23-02-26	CI
Healthlead Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-26	CI
112,200,000 Common Shares of Healthlead Public Company Limited are subject to a Lock-Up Agreement Ending on 3-DEC-2022.	22-12-02	CI
Healthlead Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14	CI
Healthlead Public Company Limited Announces Executive Changes	22-09-05	CI
Healthlead Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-11	CI
Healthlead Public Company Limited Announces Relocation of Head Office	22-07-04	CI
37,400,000 Common Shares of Healthlead Public Company Limited are subject to a Lock-Up Agreement Ending on 3-JUN-2022.	22-06-02	CI
Healthlead Public Company Limited Announces Executive Changes	22-05-31	CI
Healthlead Public Company Limited Approves Dividend for the Year 2021, Payable on 20 May 2022	22-05-16	CI
Healthlead Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-16	CI
Healthlead Public Company Limited Announces Change of Head Office’s Address	22-02-27	CI
Healthlead Public Company Limited Proposes Dividend for the Year 2021, Payable on 20 May 2022	22-02-27	CI
Healthlead Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2021	22-02-25	CI
Healthlead Public Company Limited has completed an IPO in the amount of THB 705.6 million.	21-12-02	CI

Chart Healthlead

Duration

Period

More charts

Company Profile

Healthlead Public Company Limited is a Thailand-based holding company. The principal businesses of the Company and its subsidiaries include pharmacy business distributing medicines, medical supplies, cosmeceuticals, supplements, medical devices, and other healthcare products as well as in business regarding invention business, developing, importing, and distributing healthcare products. It operates pharmacies under four brands namely Icare, Pharmax, vitaminclub, and Super Drug. The Company sells more than 10,000 stock-keeping units (SKUs) of medical supplies, cosmeceuticals, dietary supplements, medical equipment, and healthcare products via these pharmacies in response to customersâ various needs. Its pharmacies feature medicines, dietary supplements, medical equipment, household utensils, external healthcare products, and consumer goods. Its PRIME brand is a dietary supplement product, which includes PRIME Hibiki Collagen Pure and PRIME Acerola Cherry Extract 1200 MG.

Sector

Drug Retailers

Calendar

2024-08-08 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Healthlead

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

11.2 THB

Average target price

12 THB

Spread / Average Target

+7.14%

Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Drug Retailers

	1st Jan change	Capi.
HEALTHLEAD	+7.69%	85.09M
WALGREENS BOOTS ALLIANCE, INC.	-36.12%	15.37B
JD HEALTH INTERNATIONAL INC.	-27.24%	12.7B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED	-26.65%	6.89B
MATSUKIYOCOCOKARA & CO.	-6.57%	6.26B
YIFENG PHARMACY CHAIN CO., LTD.	+15.31%	6.2B
CORPORATIVO FRAGUA, S.A.B. DE C.V.	+75.54%	4.96B
NAHDI MEDICAL COMPANY	-2.34%	4.63B
CLICKS GROUP LIMITED	-6.60%	3.98B
DASHENLIN PHARMACEUTICAL GROUP CO., LTD.	-10.64%	3.56B

Other Drug Retailers

Healthlead

Equities

HL

THA598010009

Drug Retailers

Healthlead Public Company Limited Proposes Cash Dividend for the Period from January 1, 2022 to December 31, 2022, Payable on May 11, 2023

Latest news about Healthlead

Chart Healthlead

Company Profile

Income Statement Evolution

Ratings for Healthlead

Analysts' Consensus

EPS Revisions

Quarterly revenue - Rate of surprise

Sector Other Drug Retailers